Sequent Scientific (BOM:512529) ROCE % : 8.59% (As of Dec. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Sequent Scientific ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sequent Scientific's annualized ROCE % for the quarter that ended in Dec. 2024 was 8.59%.

Sequent Scientific ROCE % Historical Data

The historical data trend for Sequent Scientific's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific ROCE % Chart

Sequent Scientific Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

13.20

16.40

7.10

-11.31

-0.87

Sequent Scientific Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															6.26	5.88	12.43	8.27	8.59

Sequent Scientific ROCE % Calculation

Sequent Scientific's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	-82.23	/	( ( (15291.23 - 5587.58)	+	(15403.84 - 6269.9) )	/ 2 )
	=	-82.23	/	( (9703.65	+	9133.94)	/ 2 )
	=	-82.23	/	9418.795
	=	-0.87 %

Sequent Scientific's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	922	/	( ( (15620.5 - 4887.9)	+	(0 - 0) )	/ 1 )
	=	922	/	( ( 10732.6	+	0 )	/ 1 )
	=	922	/	10732.6
	=	8.59 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Sequent Scientific (BOM:512529) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sequent Scientific ROCE % Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequent Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (BOM:512529) » Definitions » ROCE %

Traded in Other Exchanges

SEQUENT:India

Address

Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604

Website

https://www.sequent.in

Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines